Add this topic to your myFT Digest for news straight to your inbox
New chief needs to make marked improvements if he is to resist pressure to sell
Medical devices maker rejigs management amid pressure from activist investor
Citi analysts turn negative on H&M while SocGen downgrades Sky
JPMorgan Cazenove says UK medical devices group has capacity for share buybacks or acquisitions
A once-a-decade tendering process is far from optimal
Chief Olivier Bohuon refuses to comment on activist pressure to break up medical devices group
Fund wants group to explore disposals that could boost attraction as takeover target
Hedge fund’s move comes as US activists turn to Europe for more opportunities
Change of chief and an activist investor may presage corporate activity
Olivier Bohuon will have led the medical device maker for seven years
UK stocks dip despite well-received update from Royal Dutch Shell
Sharp jump in gilt yields weighs on wider market for UK stocks
International Edition